EPTIFIBATIDE for Antiplatelet therapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 60 adverse event reports in the FDA FAERS database where EPTIFIBATIDE was used for Antiplatelet therapy.
Most Reported Side Effects for EPTIFIBATIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product use in unapproved indication | 61 | 13.2% | 0 | 1 |
| Thrombocytopenia | 58 | 12.6% | 0 | 24 |
| Drug ineffective | 39 | 8.4% | 9 | 22 |
| Off label use | 31 | 6.7% | 1 | 4 |
| Haemoglobin decreased | 30 | 6.5% | 3 | 15 |
| Haemorrhage | 28 | 6.1% | 5 | 7 |
| Vascular stent thrombosis | 19 | 4.1% | 0 | 16 |
| Condition aggravated | 14 | 3.0% | 7 | 10 |
| Gastrointestinal haemorrhage | 14 | 3.0% | 1 | 9 |
| Haematoma | 14 | 3.0% | 4 | 9 |
| Product use issue | 14 | 3.0% | 1 | 2 |
| Hypotension | 13 | 2.8% | 6 | 8 |
| Pulmonary alveolar haemorrhage | 13 | 2.8% | 6 | 7 |
| Subarachnoid haemorrhage | 13 | 2.8% | 3 | 7 |
| Haemoptysis | 12 | 2.6% | 2 | 7 |
Other Indications for EPTIFIBATIDE
Product used for unknown indication (57)
Acute myocardial infarction (36)
Cerebral artery occlusion (29)
Thrombosis (26)
Coronary artery thrombosis (18)
Percutaneous coronary intervention (17)
Myocardial infarction (13)
Acute coronary syndrome (12)
Thrombosis in device (12)
Ischaemic stroke (11)
Other Drugs Used for Antiplatelet therapy
CLOPIDOGREL BISULFATE (3,520)
ASPIRIN (3,410)
TIROFIBAN (1,513)
TICAGRELOR (660)
PRASUGREL (235)
HEPARIN (96)
ASPIRIN DL-LYSINE (59)
WARFARIN (59)
CILOSTAZOL (53)
CANGRELOR (41)